Compare PSQH & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSQH | VNRX |
|---|---|---|
| Founded | 2021 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.3M | 24.5M |
| IPO Year | 2021 | 2012 |
| Metric | PSQH | VNRX |
|---|---|---|
| Price | $6.34 | $0.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.67 |
| AVG Volume (30 Days) | 534.5K | ★ 696.5K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.00 | 38.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,685,987.00 | $1,727,384.00 |
| Revenue This Year | $80.20 | $355.66 |
| Revenue Next Year | $34.74 | $849.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1096.61 | 40.04 |
| 52 Week Low | $0.36 | $0.13 |
| 52 Week High | $6.94 | $3.26 |
| Indicator | PSQH | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 74.78 | 22.74 |
| Support Level | $0.61 | $0.18 |
| Resistance Level | N/A | $0.91 |
| Average True Range (ATR) | 0.64 | 0.07 |
| MACD | 0.19 | -0.00 |
| Stochastic Oscillator | 94.85 | 11.12 |
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.